- Home
- RDCM vs BIOA Comparison
RDCM vs BIOA Comparison
Compare RDCM & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- BIOA
- Stock Information
- Founded
- RDCM 1985
- BIOA 2015
- Country
- RDCM Israel
- BIOA United States
- Employees
- RDCM N/A
- BIOA N/A
- Industry
- RDCM Computer peripheral equipment
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- RDCM Technology
- BIOA Health Care
- Exchange
- RDCM Nasdaq
- BIOA Nasdaq
- Market Cap
- RDCM 215.2M
- BIOA 175.7M
- IPO Year
- RDCM 1997
- BIOA 2024
- Fundamental
- Price
- RDCM $13.09
- BIOA $7.92
- Analyst Decision
- RDCM Strong Buy
- BIOA Hold
- Analyst Count
- RDCM 1
- BIOA 4
- Target Price
- RDCM $18.00
- BIOA $9.00
- AVG Volume (30 Days)
- RDCM 43.7K
- BIOA 662.4K
- Earning Date
- RDCM 11-12-2025
- BIOA 11-06-2025
- Dividend Yield
- RDCM N/A
- BIOA N/A
- EPS Growth
- RDCM 37.57
- BIOA N/A
- EPS
- RDCM 0.64
- BIOA N/A
- Revenue
- RDCM $68,901,000.00
- BIOA $5,917,000.00
- Revenue This Year
- RDCM $18.07
- BIOA N/A
- Revenue Next Year
- RDCM $11.52
- BIOA N/A
- P/E Ratio
- RDCM $19.98
- BIOA N/A
- Revenue Growth
- RDCM 17.27
- BIOA N/A
- 52 Week Low
- RDCM $9.88
- BIOA $2.88
- 52 Week High
- RDCM $15.98
- BIOA $21.45
- Technical
- Relative Strength Index (RSI)
- RDCM 44.27
- BIOA 63.60
- Support Level
- RDCM $12.60
- BIOA $6.75
- Resistance Level
- RDCM $14.44
- BIOA $8.14
- Average True Range (ATR)
- RDCM 0.60
- BIOA 0.44
- MACD
- RDCM -0.05
- BIOA -0.03
- Stochastic Oscillator
- RDCM 24.76
- BIOA 72.86
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.